4.63
price up icon0.87%   0.04
after-market Handel nachbörslich: 4.53 -0.10 -2.16%
loading
Schlusskurs vom Vortag:
$4.59
Offen:
$4.55
24-Stunden-Volumen:
463.34K
Relative Volume:
0.60
Marktkapitalisierung:
$408.97M
Einnahmen:
$73.48M
Nettoeinkommen (Verlust:
$-108.30M
KGV:
-2.0578
EPS:
-2.25
Netto-Cashflow:
$-67.17M
1W Leistung:
-3.14%
1M Leistung:
+21.84%
6M Leistung:
+16.62%
1J Leistung:
+253.44%
1-Tages-Spanne:
Value
$4.47
$4.72
1-Wochen-Bereich:
Value
$4.47
$5.06
52-Wochen-Spanne:
Value
$1.135
$7.20

Personalis Inc Stock (PSNL) Company Profile

Name
Firmenname
Personalis Inc
Name
Telefon
650-752-1300
Name
Adresse
6600 DUMBARTON CIRCLE, FREMONT, CA
Name
Mitarbeiter
229
Name
Twitter
@PersonalisInc
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
PSNL's Discussions on Twitter

Vergleichen Sie PSNL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
PSNL
Personalis Inc
4.63 422.19M 73.48M -108.30M -67.17M -2.25
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
402.82 148.60B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
189.90 132.07B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
513.36 40.34B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
111.92 30.82B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
140.33 23.70B 15.50B 1.33B 2.16B 7.34

Personalis Inc Stock (PSNL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-15 Eingeleitet Guggenheim Buy
2025-03-17 Eingeleitet Craig Hallum Buy
2023-02-06 Hochstufung Needham Hold → Buy
2022-01-07 Hochstufung BofA Securities Neutral → Buy
2021-11-05 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-11-03 Herabstufung Needham Buy → Hold
2021-10-15 Fortgesetzt Cowen Outperform
2021-09-20 Bestätigt Needham Buy
2021-05-06 Hochstufung Oppenheimer Perform → Outperform
2021-01-28 Eingeleitet Truist Buy
2021-01-04 Herabstufung BofA Securities Buy → Neutral
2020-11-12 Bestätigt Needham Buy
2020-11-06 Herabstufung Oppenheimer Outperform → Perform
2020-10-19 Eingeleitet Citigroup Buy
2020-10-08 Eingeleitet BTIG Research Buy
2020-08-27 Eingeleitet H.C. Wainwright Buy
2020-08-18 Eingeleitet Needham Buy
2019-09-26 Hochstufung BofA/Merrill Neutral → Buy
2019-07-15 Eingeleitet BofA/Merrill Neutral
2019-07-15 Eingeleitet Cowen Outperform
2019-07-15 Eingeleitet Morgan Stanley Overweight
2019-07-15 Eingeleitet Oppenheimer Outperform
Alle ansehen

Personalis Inc Aktie (PSNL) Neueste Nachrichten

pulisher
May 27, 2025

Millennium Management LLC Has $7.61 Million Stock Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World

May 27, 2025
pulisher
May 26, 2025

BNP Paribas Financial Markets Acquires 71,721 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World

May 26, 2025
pulisher
May 22, 2025

Personalis and Academic Partners to Present Latest Data on Ultra - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection - Yahoo Finance

May 22, 2025
pulisher
May 19, 2025

Personalis Holds Virtual Annual Stockholders Meeting - TipRanks

May 19, 2025
pulisher
May 19, 2025

PSNL to Discuss Future Plans in Upcoming Virtual Meeting | PSNL Stock News - GuruFocus

May 19, 2025
pulisher
May 18, 2025

Brokerages Set Personalis, Inc. (NASDAQ:PSNL) PT at $8.00 - Defense World

May 18, 2025
pulisher
May 17, 2025

Personalis Inc (PSNL): A Sitting Duck With -162.63% Upside Potential - Stocksregister

May 17, 2025
pulisher
May 17, 2025

Guggenheim Begins Coverage on Personalis (NASDAQ:PSNL) - Defense World

May 17, 2025
pulisher
May 16, 2025

Personalis, Inc. (NASDAQ:PSNL) Stake Raised by Jane Street Group LLC - Defense World

May 16, 2025
pulisher
May 16, 2025

Jane Street Group LLC Has $2.32 Million Stock Holdings in Personalis, Inc. (NASDAQ:PSNL) - The AM Reporter

May 16, 2025
pulisher
May 16, 2025

Personalis, Inc. (NASDAQ:PSNL) Shares Acquired by Stifel Financial Corp - Defense World

May 16, 2025
pulisher
May 15, 2025

Guggenheim Initiates Buy Rating for Personalis (PSNL) with $6 Ta - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Guggenheim starts Personalis with a Buy, cites ‘best-in-class infrastructure’ - TipRanks

May 15, 2025
pulisher
May 15, 2025

Guggenheim Initiates Buy Rating for Personalis (PSNL) with $6 Target | PSNL Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Guggenheim Initiates Personalis at Buy With $6 Price Target - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Guggenheim Starts Coverage on Personalis (PSNL) with Buy Rating - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Guggenheim Starts Coverage on Personalis (PSNL) with Buy Rating | PSNL Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Dimensional Fund Advisors LP Purchases 242,141 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World

May 15, 2025
pulisher
May 15, 2025

Raymond James Financial Inc. Takes Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World

May 15, 2025
pulisher
May 14, 2025

Leading Genomics Company Personalis Takes Center Stage at Major Craig-Hallum Investor Conference - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference - Yahoo Finance

May 14, 2025
pulisher
May 12, 2025

Personalis stock price target raised to $9 at H.C. Wainwright By Investing.com - Investing.com Nigeria

May 12, 2025
pulisher
May 12, 2025

What is HC Wainwright’s Estimate for Personalis Q2 Earnings? - Defense World

May 12, 2025
pulisher
May 10, 2025

Personalis reiterates 2025 revenue guidance of $80M-$90M with focus on MRD testing growth - MSN

May 10, 2025
pulisher
May 09, 2025

HC Wainwright Raises Personalis (NASDAQ:PSNL) Price Target to $9.00 - Defense World

May 09, 2025
pulisher
May 09, 2025

Personalis (PSNL) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 09, 2025
pulisher
May 08, 2025

Companies Like Personalis (NASDAQ:PSNL) Are In A Position To Invest In Growth - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Barclays PLC Acquires 43,900 Shares of Personalis, Inc. (NASDAQ:PSNL) - The AM Reporter

May 08, 2025
pulisher
May 08, 2025

JPMorgan Chase & Co. Has $34,000 Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World

May 08, 2025
pulisher
May 08, 2025

Barclays PLC Increases Stock Holdings in Personalis, Inc. (NASDAQ:PSNL) - Defense World

May 08, 2025
pulisher
May 07, 2025

Personalis stock price target raised to $9 at H.C. Wainwright - Investing.com Australia

May 07, 2025
pulisher
May 07, 2025

Personalis Inc.: Strong Financial Performance and Promising Future Prospects Drive Buy Rating - TipRanks

May 07, 2025
pulisher
May 07, 2025

Will Personalis' Testing Growth And MRD Strategy Pay Off In 2025? - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Analyst Expectations For Personalis's Future - Benzinga

May 07, 2025
pulisher
May 07, 2025

Personalis, Inc. (NASDAQ:PSNL) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025
pulisher
May 07, 2025

Personalis (PSNL) Receives Price Target Boost from Analyst | PSNL Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

H.C. Wainwright Increases Price Target for Personalis (PSNL) to $9 | PSNL Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Personalis Reports Strong Q1 Growth in Genomics - TipRanks

May 07, 2025
pulisher
May 07, 2025

Personalis Inc (PSNL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Earnings call transcript: Personalis beats Q1 2025 earnings, stock rises By Investing.com - Investing.com South Africa

May 07, 2025
pulisher
May 07, 2025

Personalis Inc (PSNL) Q1 2025 Earnings Call Highlights: Strong R - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Personalis Inc (PSNL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... By GuruFocus - Investing.com Canada

May 07, 2025
pulisher
May 07, 2025

Personalis Reports First Quarter 2025 Financial Results - BioSpace

May 07, 2025
pulisher
May 06, 2025

Personalis: Q1 Earnings Snapshot - CTPost

May 06, 2025
pulisher
May 06, 2025

Personalis (PSNL) Q1 2025 Earnings Reflects Strong Growth in Molecular Tests - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Personalis (PSNL) Q1 2025 Earnings Reflects Strong Growth in Mol - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Earnings call transcript: Personalis beats Q1 2025 earnings, stock rises - Investing.com

May 06, 2025
pulisher
May 06, 2025

Personalis (PSNL) Reports Strong Q1 Revenue and Testing Growth | - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Personalis Inc (PSNL) Q1 2025 Earnings: EPS of -$0.24 Beats Esti - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Personalis Inc (PSNL) Q1 2025 Earnings: EPS of -$0.24 Beats Estimate, Revenue at $13.6M Misses Estimate - GuruFocus

May 06, 2025

Finanzdaten der Personalis Inc-Aktie (PSNL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research DGX
$173.34
price up icon 0.78%
diagnostics_research WAT
$349.24
price down icon 1.71%
diagnostics_research LH
$248.97
price up icon 0.90%
$157.73
price down icon 0.20%
diagnostics_research MTD
$1,155.52
price down icon 1.51%
diagnostics_research IQV
$140.33
price down icon 0.49%
Kapitalisierung:     |  Volumen (24h):